|
Policy & Politics G8 Summit Participants to Endorse Formation of HIV/AIDS Vaccine ConsortiumJune 9, 2004 A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information! U.S. officials on Tuesday announced that participants at the three-day Group of Eight summit in Sea Island, Ga., have reached an agreement to form a global consortium to "collaborate and share information" to develop an HIV/AIDS vaccine "as quickly as possible," London's Guardian reports (Teather, Guardian, 6/9). G8 officials from the United States, Japan, Germany, France, Britain, Italy, Canada and Russia at the summit announced the formation of a Global HIV Vaccine Enterprise program to speed the development of an HIV/AIDS vaccine and "streamline" research and development efforts, according to the Indianapolis Star (Indianapolis Star, 6/9). The International AIDS Vaccine Initiative on Tuesday lauded the creation of the vaccine enterprise. IAVI, which is a founding member of the consortium, said in a statement, "A new level of global collaboration in AIDS vaccine research and development is critical, so that the most promising vaccine candidates, regardless of country of origin, are prioritized for human testing" (IAVI release, 6/9). Summit participants reached consensus on three other issues, including combating famine in East Africa, eradicating polio by the end of 2005 and reducing poverty, the Star reports (Indianapolis Star, 6/9). Development, Debt Relief Reaction Matthew Bishop, business editor for the Economist magazine, said on Tuesday in a commentary on MPR's "Marketplace Morning Report" that at the Copenhagen Consensus held earlier this month in Denmark, "some of the world's top economists concluded that there is no better way to help the world's poor than to spend more money on preventing the spread of AIDS" (Bishop, "Marketplace Morning Report," MPR, 6/8). The conference, organized by the Environmental Assessment Institute, featured an eight-person panel of economists assembled by Danish statistician Bjorn Lomborg. Conference attendees, who included other academics, used a cost-benefit analysis to create a list of global priorities for spending on international aid efforts. The panelists considered 10 global challenges, including climate change, diseases, hunger, migration, sanitation, corruption, trade barriers, education, conflicts and financial stability. The experts concluded that programs to fight HIV/AIDS could create "extraordinarily high benefits" and prevent almost 30 million new HIV cases by 2010. They said in a statement, "Although costs are considerable, they are tiny in relation to what can be gained" (Kaiser Daily HIV/AIDS Report, 6/1). Bishop said, "It has been said that if you'd laid down all the economists in the world head to toe, they still wouldn't reach a conclusion, so if even economists can agree that AIDS is the top priority, surely it isn't beyond the leaders of the G8 to do the same" ("Marketplace Morning Report," MPR, 6/8). Back to other news for June 9, 2004
A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information! This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report.
|
|